RxSight, Inc. revenue by segment RXST

Annual Quarterly

RxSight, Inc. splits its revenue into 4 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Rxlal at $22.8 million, 93% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q3 FY2026 Sep 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024
Revenue	115	25	27	31	33	30	34	38	40
Rxlal	—	23 -11.4% share 92.8%	24 -9.3% share 89.9%	27 -0.5% share 87.5%	28 -1.2% share 86.4%	26 share 84.7%	27 share 80.3%	27 share 71.7%	29 share 70.9%
Service Warranty Service Contracts And Accessories	—	1 -8.3% share 5.5%	1 -6.3% share 5.2%	2 +14.1% share 4.9%	1 +43.5% share 4.5%	1 share 4.9%	1 share 4.5%	1 share 3.5%	1 share 2.5%
LDD	—	0 -86.5% share 1.7%	1 -73.9% share 4.9%	2 -75.0% share 7.6%	3 -72.2% share 9.1%	3 share 10.5%	5 share 15.3%	9 share 24.8%	11 share 26.5%
License And Collaboration Revenue	—	0 share 0.2%	6 share 23.9%	—	—	—	—	—	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Ophthalmic Goods (SIC 3851)
Listed as: RXST (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Aliso Viejo, CA
SEC filer status: Accelerated filer
SEC CIK: 1111485
Former names: CALHOUN VISION INC (until Mar 20, 2014)

Other Ophthalmic Goods companies

All 8 Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.